Stock Taper Net Sales: $33.9 million, up 89.7% year-over-year, exceeding guidance.
Non-GAAP Gross Profit: $16 million, more than doubling year-over-year; Non-GAAP gross margin at 47.2%, a 450 basis point increase.
Operating Expenses: Non-GAAP R&D expenses rose to $11.2 million (up 55.5% YoY), and SG&A expenses increased to $8.2 million (up 23.7% YoY).
Net Loss: Non-GAAP net loss of $1.8 million, improved by $4.1 million YoY; loss per share of $0.07.
Cash Position: $366.8 million in cash and cash equivalents, bolstered by $168 million from a follow-on offering.
Demand for Edge AI: Significant growth in demand for Edge AI solutions across various end markets, with strong performance from Apollo II, Apollo IV, and Apollo V products.
Product Development: Introduction of new SoC families (Apollo 330 Plus and Apollo 510 Light) expected to contribute to revenue in Q3 2026.
Market Expansion: Focus on diversifying into medical, industrial, and smart home markets, with expectations for revenue from these sectors to more than double in 2026.
Innovative Solutions: Launch of AI software capabilities like HeliaCORE and Helia Profiler to enhance product offerings and customer engagement.
Q3 2026 Expectations: Projected net sales between $36 million and $37 million, with a year-over-year growth of approximately 100%.
Full Year 2026 Guidance: Anticipating total net sales of approximately $135 million, despite supply constraints.
Gross Margin: Expected to remain stable between 46.5% and 47.5% in Q3, with modest year-over-year improvement anticipated for the full year.
Supply Constraints: Ongoing supply chain challenges affecting production capacity, with demand outpacing supply. Management is actively working with partners to mitigate these issues.
Operating Expenses: Significant increase in operating expenses anticipated in Q3 due to investments in product development, which may affect profitability in the near term.
Market Competition: The semiconductor industry is facing rising costs and competitive pressures, which could impact margins and growth.
Supply Constraints: CEO Esaka indicated that demand continues to rise, complicating supply chain management. While they are addressing these challenges, the exact impact on revenue potential remains uncertain.
Product Development Timeline: The Atomiq 110 product is on track for sampling in early 2027, with a meaningful revenue ramp expected by 2028.
Revenue Mix: Approximately 25% of the design funnel is from nonwearable devices, indicating growth in this segment but still trailing behind the booming wearable market.
Profitability Trajectory: Management remains focused on growth rather than immediate profitability, with no clear timeline for reaching cash flow breakeven. Overall, Ambiq Micro reported strong financial performance driven by robust demand for Edge AI solutions, while also navigating supply chain challenges and increased operating costs. The company is well-positioned for future growth, supported by a strong cash position and ongoing product development initiatives.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT